MACKO TODD D (Chief Financial Officer) sold 22.5% of their position (45K shares) of IMPACT BIOMEDICAL INC. on the open market
Open‑market sale worth $25.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/30/2026ACC: 0001493152-26-013708
Officer· Chief Financial Officer
Since Sep 2024
-45K
Net shares
Net seller
$25.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
45K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.60K
Price / share
$0.60
Trade value
$961.28
% of position
0.8%
3/25/2026
199.72K→198.12K
Common Stock
Direct
Shares
−43.40K
Price / share
$0.56
Trade value
$24.37K
% of position
21.9%
3/27/2026
198.52K→155.12K
Total
Net shares
−45K
Net value
-$25.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/25/2026 | S · Sale | −1.60K | $0.60 | $961.28 | 0.8% | 199.72K | 198.12K |
| Common Stock Direct | 3/27/2026 | S · Sale | −43.40K | $0.56 | $24.37K | 21.9% | 198.52K | 155.12K |
| Total | −45K | -$25.33K | ||||||
Derivative Transactions0
No derivative transactions reported